Health care giant sues to stop antitrust probe of pharmacy drug middlemen
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by the Federal Trade Commission to investigate industry practices. However, the suit relies on research that the health conglomerate helped pay for and was conducted by an economist who’s become wealthy arguing in support of huge mergers.
Consumers do not understand how much privacy they are giving up, largely to facilitate targeted advertising, the Federal ...
The Guardian reported social media and online video companies are collecting huge troves of your personal information on and ...
The former president touts tariffs as a cure-all, but Republican lawmakers prefer to characterize the measures as a ...
The Senate will advance a bipartisan stopgap government funding bill on Thursday after efforts to pass a similar measure in ...
The District Court for the Northern District of Texas issued a decision striking down the Federal Trade Commission’s rule banning ...
The largest ever supermarket merger was first proposed in October, 2022. Kroger announced that it planned to buy rival ...
The Texas Tribune on MSN10d
Texas leads push for faster certification of mental health professionalsOther states look to Texas as the state psychology board pushes against the new national licensing requirements.
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
Eight U.S. senators on Tuesday urged the Department of Justice and Federal Trade Commission to undertake an antitrust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback